Cancer Epidemiology (CE) The goal of the Cancer Epidemiology (CE) Program is to provide a platform to synergize research efforts of epidemiologic and clinical researchers in order to elucidate pathways to cancer occurrence and progression that can impact clinical treatment and prevention strategies. The program brings together experienced, NCI- funded epidemiologists, molecular biologists, biostatisticians, bioinformaticists and NCCC clinicians around 3 central interactive program themes: (1) population genomics, (2) emerging risk factors, and (3) life course epidemiology. Program investigators design, execute, and analyze population-based research aimed at understanding cancer etiology, second malignancies, progression, and survival, as well as develop novel methods for these lines of research. This work is based on outstanding efforts to use population-based studies of the catchment area population and also to engage in research with national and international epidemiologic resources, including clinical trials, cohort and case-control studies. Currently there are 22 members, including 3 clinical members and 1 joint member, spanning 11 departments with expertise and experience in all facets of modern molecular epidemiology. The NCCC has been instrumental in supporting the efforts of the CE program, most notably with its support of strategic, targeted recruitment efforts, including the recruitment of Chris Amos, Olga Gorlova, Jennifer Doherty, Diane Gilbert-Diamond, Scott Williams, Amarendra Das, Zhigang Li, Brock Christensen and Carmen Marsit, the latter who serves now as Co-Director of the program with Margaret Karagas. Spurred by these recruitments and their synergies with existing member interests, the present program has developed and evolved, from a broader program in Cancer Epidemiology and Chemoprevention, to focus its efforts on cancer epidemiology research and translation. The program aims to expand collaborative research efforts within its membership and across NCCC Programs, utilizing monthly program meetings to encourage these activities, which are subsequently catalyzed by pilot grants funded by NCCC. The support of the NCCC was paramount in the successful creation and funding of the new COBRE Center for Molecular Epidemiology, the development of an interdisciplinary training program in the Quantitative Population Sciences in Cancer, and a second COBRE in Integrative Biology. These initiatives have been instrumental in the recruitment of talented faculty and trainees that continue to energize and grow cancer epidemiology research. More than 580 cancer-related articles have been published over the reporting period (85 [15%] in high impact journals), with all 22 members on intra-program (158=27%) and 19 members on inter- program (74=13%) collaborations. Total funding for the program is currently $11.5M, of which $10.8M is peer- reviewed and $2.9M is from NCI. These efforts will allow the CE program to continue to perform cutting-edge molecular epidemiologic research, on the etiology and outcomes of cancer, to reduce the burden of human malignancies and impact prevention and treatment strategies.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Career Development (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Dartmouth College
United States
Zip Code
Emond, Jennifer A; Tovar, Alison; Li, Zhigang et al. (2017) FTO genotype and weight status among preadolescents: Assessing the mediating effects of obesogenic appetitive traits. Appetite 117:321-329
Rapuano, Kristina M; Zieselman, Amanda L; Kelley, William M et al. (2017) Genetic risk for obesity predicts nucleus accumbens size and responsivity to real-world food cues. Proc Natl Acad Sci U S A 114:160-165
Carroll, A M; Cheng, R; Collie-Duguid, E S R et al. (2017) Fine-mapping of genes determining extrafusal fiber properties in murine soleus muscle. Physiol Genomics 49:141-150
Fang, Jun; Jia, Jinping; Makowski, Matthew et al. (2017) Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148. Nat Commun 8:15034
Pan, Yongchu; Liu, Hongliang; Wang, Yanru et al. (2017) Associations between genetic variants in mRNA splicing-related genes and risk of lung cancer: a pathway-based analysis from published GWASs. Sci Rep 7:44634
Rothwell, Simon; Cooper, Robert G; Lundberg, Ingrid E et al. (2017) Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum. Arthritis Rheumatol 69:1090-1099
Hampsch, Riley A; Shee, Kevin; Bates, Darcy et al. (2017) Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer. Oncotarget 8:21806-21817
Barr, Paul J; Forcino, Rachel C; Thompson, Rachel et al. (2017) Evaluating CollaboRATE in a clinical setting: analysis of mode effects on scores, response rates and costs of data collection. BMJ Open 7:e014681
Melin, Beatrice S; Barnholtz-Sloan, Jill S; Wrensch, Margaret R et al. (2017) Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nat Genet 49:789-794
Adachi-Mejia, Anna M; Lee, Chanam; Lee, Chunkuen et al. (2017) Geographic variation in the relationship between body mass index and the built environment. Prev Med 100:33-40

Showing the most recent 10 out of 1659 publications